---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-231974"
form_type: "8-K"
ticker: "BLCO"
cik: "0001860742"
company_name: "Bausch & Lomb Corp"
filed_at: "2023-09-11T23:59:59+00:00"
generated_at: "2026-06-10T21:50:47.291468+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb launches $1.4B notes offering and $500M term loans to finance XIIDRA acquisition

## Summary
- $1.4B senior secured notes due 2028 offered via Bausch + Lomb Escrow Corp.; $500M term B loans also planned.
- Proceeds to fund acquisition of XIIDRA and other ophthalmology assets, pay fees, and repay existing debt.
- Notes offering not conditioned on acquisition close; if not closed by Sept 30, 2024, notes redeemed at principal plus interest.
- Purchase price allocation adjusted: prepaid assets reduced $22M, other liabilities cut $12M, goodwill up $10M; no impact on revenue or adjusted EBITDA.
- Acquisition expected to close around end of September 2023; term loan facility conditioned on completion.

## SEC filing metadata
- accession: 0001193125-23-231974
- form_type: 8-K
- ticker: BLCO
- cik: 0001860742
- company_name: Bausch & Lomb Corp
- filed_at: 2023-09-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860742/000119312523231974/0001193125-23-231974-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860742/000119312523231974/d497585d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-231974
- JSON: https://secwatch.observer/filing/0001193125-23-231974.json
- Plain text: https://secwatch.observer/filing/0001193125-23-231974.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.